Open AccessAssessment, Pretreatment and Treatment of Pharmaceutical Production Wastewaters in the Roche Group
Author(s) -
Jürg Oliver Straub,
Christoph Acklin,
Jürgen Klemmer,
Marco Aurélio Kurlbaum,
Ли Бин,
Martin Studer,
Roland Zurbrügg,
Andreas Häner
Publication year - 2020
Publication title -
chimia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.387
H-Index - 55
eISSN - 2673-2424
pISSN - 0009-4293
DOI - 10.2533/chimia.2020.161
Subject(s) - production (economics) , pharmaceutical industry , business , medicine , pharmacology , economics , macroeconomics
The manufacturing of pharmaceuticals also produces wastes, mainly wastewaters (WWs). These WWs must be responsibly managed. Sometimes, the organic contents of these WWs are not easily removable in standard WW treatment, hence technical options must be investigated to pretreat such WWs in order to remove or destroy the recalcitrant compounds, mostly the active pharmaceutical ingredients themselves. This contribution from a pharmaceuticals company describes WW assessment and management principles, the search for pretreatment options and several case studies on WW (pre)treatment at some pharma production sites of the Roche Group.